• Users Online: 189
  • Print this page
  • Email this page
Year : 2014  |  Volume : 3  |  Issue : 1  |  Page : 3

Economic impacts of treatment for type II or III thoracoabdominal aortic aneurysm in the United States

1 European Company of Strategic Intelligence, Paris, France
2 Cardiovascular Surgery, Parly II Private Hospital, Le Chesnay, France
3 Vascular Surgery, Georges Pompidou European Hospital, Paris, France
4 Vascular Surgery, Medical and Surgical Centre for Heart and Vessels, Sale, Morocco
5 Cardiac Surgery, University Hospital, Besancon, France
6 Cardiology Department, Claude Galien Private Hospital, Quincy-sous-Senart, France
7 Cardiac Surgery, Georges Pompidou European Hospital, Paris, France

Correspondence Address:
Claude Vaislic
Cardiovascular Surgery, Parly II Private Hospital, Le Chesnay
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.5812/cardiovascmed.9568

Get Permissions

Background: Current treatment for extensive thoracoabdominal aortic aneurysms (TAAAs) involves high-risk surgical and endovascular repairs, with a hospital mortality exceeding 20%, and a postoperative paraplegia rate beyond 10.5%. Objectives: The aim of this study was to present an estimation of the economic impacts of surgical and endovascular treatments of types II and III TAAAs in the US as well as the economic consequences of the elimination of spinal cord injury and mortality via an endovascular repair of extensive TAAAs (1). Materials and Methods: We compared the current hospital charges of endovascular and surgical repair of extensive TAAAs, also provided a cost analysis of health care charges resulting from paraplegia in the United States, and determined the prevalence of extensive TAAAs found yearly during autopsies in the U.S. Based on the figures gathered and the frequency of Thoracic Aortic Aneurysms per year, we were able to calculate the nationwide inpatient hospital charges, the total average expenses affected by paraplegia during the first 12 months after the repair, the total average expenses after paraplegia for each subsequent year, mortality rate at 30 days and one year, and the number of extensive TAAAs ruptures. Results: The current nationwide inpatient hospital charges for type II or III TAAA repair cost $12484324 and $37612665 for endovascular repair and surgical repair respectively, and the total average expenses for patients affected by paraplegia during the first 12-month were $4882291 and $23179110 after endovascular repair and surgical repair respectively. The nationwide average expense after 10 years for patients undergoing surgical repair and affected by paraplegia is $33421910 and $6,316,183 for patients undergoing endovascular repair. Moreover, 55 patients with a type II or type III TAAA died after 30 days, and 100 after 1 year. The potential risk of type II or III TAAA ruptures is totally 1637 in a year. Conclusions: Major economic impacts of type II or III TAAA repairs in the United States have been identified. An endovascular repair excluding spinal cord injury and mortality with the same average costs as present endovascular treatments makes it possible to save at least $53189742 after one year, 100 lives of operated patients would be saved after one year, and 1637 type II and III TAAA ruptures would be avoided yearly.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded81    
    Comments [Add]    
    Cited by others 3    

Recommend this journal